A new report by UNAIDS, Power to the people, released ahead of World AIDS Day, shows that where people and communities living with and affected by HIV are engaged in decision-making and HIV service delivery, new infections decline and more people living with HIV gain access to treatment. When people have the power to choose, to know, to thrive, to demand and to work together, lives are saved,…
In the HERIZON BTC 01 trial for patients with HER2-positive biliary tract cancer (BTC) previously treated with systemic therapy, zanidatamab improved the objective response rate,…
Clinical trials are pivotal for medical advancements, yet recruiting participants remains a significant challenge due to complex eligibility criteria and various barriers. Traditional manual screening…
The field of rare cancer research is rapidly transforming, marked by significant progress in clinical trials and treatment strategies. Rare cancers, as defined by the…
Nature Medicine – The ONCOBIOME network has generated new tools to measure dysbiosis and completed numerous trials aimed at modifying the microbiota to enhance cancer…
ABSTRACTIntroduction. Rare solid tumors account for one-quarter of cancers among adults in the United States, but few resources have been devoted to their treatment. We…
Nature Medicine – The ONCOBIOME network has generated new tools to measure dysbiosis and completed numerous trials aimed at modifying the microbiota to enhance cancer…
Nature Medicine – In a phase 1/2 trial in patients with advanced non-small-cell lung cancer (NSCLC), followed by a phase 2 trial in an EGFR-mutant…
This past year, 2024, brought many exciting practice-changing publications to JAMA Oncology across a wide variety of topics. Throughout the year, we published several randomized…
This cohort study examines chromosomal copy number alterations that could be used to improve the current World Health Organization grading of meningioma
This Medical News article is an interview with Stanford University’s Jonathan Chen, MD, PhD, and Ethan Goh, MBBS, MS, about their research on AI tools…
